Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRA · BSE: 540788 · Healthcare · 31 announcements

Share price: ₹113.25
Market cap: ₹116.6 Cr
Revenue (annual): ₹24.98 Cr
Net profit (annual): ₹0.05 Cr
P/E (TTM): -257.6×Sector 53.1×
Promoter holding: 46.58%+28.19% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Buying 7 Other Announcement 3 Open Offer 3 Management Change 3 Financial Results 3 Board Meeting Date 3 Promoter Buying (Off-Market) 2 Debt & Borrowing 2 Annual General Meeting 2 Promoter Reclassification 1 Fund Raise 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

15 Apr 2026 13:00 IST BSE

Debt & Borrowing

Aspira Pathlab & Diagnostics Debt & Borrowing

Aspira Pathlab & Diagnostics Ltd informed BSE that it does not qualify as a Large Corporate for FY 2025-26 under SEBI criteria. Consequently, the mandatory requirement to raise 25% of incremental borrowings through debt securities is not applicable. The company reported nil incremental borrowing and nil debt security issuance for the period.

Read the filing ↗

15 Apr 2026 12:51 IST BSE

Debt & Borrowing

Aspira Pathlab & Diagnostics Debt & Borrowing

Aspira Pathlab & Diagnostics Limited confirmed it is not identified as a Large Corporate as of March 31, 2026. The company reported zero outstanding borrowings and filed the disclosure in compliance with SEBI debt-raising norms for large entities.

Read the filing ↗